Hey Nitin,
The loan is given to wholly owned subsidiary based in Europe. As per the lastest guidance in concall, the management is pushing hard to break into the European market and sees and uptick to 3% contribution there.
And as you well know, for Transfer Pricing reasons the loan has to be offered at appropriate rate of interest.

Further the company has completed the acquisition of Decision Point Analytics which mostly caters Gen AI transformation space and the management expects significant synergies and cross selling through this. Due to the seasonal nature of this business, you’ll see the numbers consolidating from Q2.

They have purchased it for Rs.10 lacs. In Schedule 14 of Consolidated, they have shown Investment in Waldent at Rs.10 lacs to calculate the Goodwill amount. The acquisition amount is also mentioned in clause (iii) of Annexure A of the Audit Report of Standalone Financials. In Standalone Balance Sheet, it is given as Non Current Investment but Schedule 14 is missing which should have ideally mentioned the details. It is also mentioned in Standalone Cash Flow Statement Part B as “Investment in Equity Share (Related Party)” but the name Waldent is not mentioned.

I’m tracking this stock closely. No news/corp announcement updates as such.
They might have made some progress in Cyberpower ( my best guess).
I went through your research as well, I have a slightly different view.

Stock is up 30% in less than a month. Anyone aware of what is happening?

Thanks for your response. Its not acquisition of subsidiary but acquisition of promoter owned entity which became wholly owned subsidiary post acquisition. Will the accounting treatment remain same as you mentioned above?